- Home
- HWKN vs CNTA Comparison
HWKN vs CNTA Comparison
Compare HWKN & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HWKN
- CNTA
- Stock Information
- Founded
- HWKN 1938
- CNTA 2020
- Country
- HWKN United States
- CNTA United Kingdom
- Employees
- HWKN N/A
- CNTA N/A
- Industry
- HWKN Specialty Chemicals
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- HWKN Consumer Discretionary
- CNTA Health Care
- Exchange
- HWKN Nasdaq
- CNTA Nasdaq
- Market Cap
- HWKN 2.4B
- CNTA 2.2B
- IPO Year
- HWKN N/A
- CNTA 2021
- Fundamental
- Price
- HWKN $104.41
- CNTA $16.63
- Analyst Decision
- HWKN Hold
- CNTA Strong Buy
- Analyst Count
- HWKN 1
- CNTA 8
- Target Price
- HWKN $122.00
- CNTA $23.00
- AVG Volume (30 Days)
- HWKN 158.6K
- CNTA 964.8K
- Earning Date
- HWKN 01-29-2025
- CNTA 03-27-2025
- Dividend Yield
- HWKN 0.69%
- CNTA N/A
- EPS Growth
- HWKN 12.32
- CNTA N/A
- EPS
- HWKN 3.91
- CNTA N/A
- Revenue
- HWKN $952,133,000.00
- CNTA $6,853,000.00
- Revenue This Year
- HWKN $6.21
- CNTA N/A
- Revenue Next Year
- HWKN $5.81
- CNTA N/A
- P/E Ratio
- HWKN $26.55
- CNTA N/A
- Revenue Growth
- HWKN 3.01
- CNTA N/A
- 52 Week Low
- HWKN $67.85
- CNTA $7.75
- 52 Week High
- HWKN $139.55
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- HWKN 36.40
- CNTA 48.19
- Support Level
- HWKN $109.62
- CNTA $15.50
- Resistance Level
- HWKN $112.49
- CNTA $18.55
- Average True Range (ATR)
- HWKN 3.72
- CNTA 1.25
- MACD
- HWKN -0.37
- CNTA -0.12
- Stochastic Oscillator
- HWKN 7.26
- CNTA 31.57
About HWKN Hawkins Inc.
Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.